These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 16365407)
1. Reduced ability of neonatal and early-life bone marrow stromal cells to support plasmablast survival. Pihlgren M; Friedli M; Tougne C; Rochat AF; Lambert PH; Siegrist CA J Immunol; 2006 Jan; 176(1):165-72. PubMed ID: 16365407 [TBL] [Abstract][Full Text] [Related]
2. APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells. Belnoue E; Pihlgren M; McGaha TL; Tougne C; Rochat AF; Bossen C; Schneider P; Huard B; Lambert PH; Siegrist CA Blood; 2008 Mar; 111(5):2755-64. PubMed ID: 18180376 [TBL] [Abstract][Full Text] [Related]
3. Delayed and deficient establishment of the long-term bone marrow plasma cell pool during early life. Pihlgren M; Schallert N; Tougne C; Bozzotti P; Kovarik J; Fulurija A; Kosco-Vilbois M; Lambert PH; Siegrist CA Eur J Immunol; 2001 Mar; 31(3):939-46. PubMed ID: 11241299 [TBL] [Abstract][Full Text] [Related]
4. Expression of stromal cell-derived factor-1/pre-B cell growth-stimulating factor receptor, CXC chemokine receptor 4, on CD34+ human bone marrow cells is a phenotypic alteration for committed lymphoid progenitors. Ishii T; Nishihara M; Ma F; Ebihara Y; Tsuji K; Asano S; Nakahata T; Maekawa T J Immunol; 1999 Oct; 163(7):3612-20. PubMed ID: 10490954 [TBL] [Abstract][Full Text] [Related]
6. Contribution of stromal cells to the migration, function and retention of plasma cells in human spleen: potential roles of CXCL12, IL-6 and CD54. Ellyard JI; Avery DT; Mackay CR; Tangye SG Eur J Immunol; 2005 Mar; 35(3):699-708. PubMed ID: 15714584 [TBL] [Abstract][Full Text] [Related]
7. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Medina F; Segundo C; Campos-Caro A; González-García I; Brieva JA Blood; 2002 Mar; 99(6):2154-61. PubMed ID: 11877292 [TBL] [Abstract][Full Text] [Related]
8. Short-lived and long-lived bone marrow plasma cells are derived from a novel precursor population. O'Connor BP; Cascalho M; Noelle RJ J Exp Med; 2002 Mar; 195(6):737-45. PubMed ID: 11901199 [TBL] [Abstract][Full Text] [Related]
9. Signal via lymphotoxin-beta R on bone marrow stromal cells is required for an early checkpoint of NK cell development. Wu Q; Sun Y; Wang J; Lin X; Wang Y; Pegg LE; Fütterer A; Pfeffer K; Fu YX J Immunol; 2001 Feb; 166(3):1684-9. PubMed ID: 11160211 [TBL] [Abstract][Full Text] [Related]
10. VCAM-1-positive stromal cells from human bone marrow producing cytokines for B lineage progenitors and for plasma cells: SDF-1, flt3L, and BAFF. Schaumann DH; Tuischer J; Ebell W; Manz RA; Lauster R Mol Immunol; 2007 Mar; 44(7):1606-12. PubMed ID: 17067679 [TBL] [Abstract][Full Text] [Related]
11. Oncostatin m maintains the hematopoietic microenvironment and retains hematopoietic progenitors in the bone marrow. Minehata K; Takeuchi M; Hirabayashi Y; Inoue T; Donovan PJ; Tanaka M; Miyajima A Int J Hematol; 2006 Nov; 84(4):319-27. PubMed ID: 17118758 [TBL] [Abstract][Full Text] [Related]
12. Inflammation controls B lymphopoiesis by regulating chemokine CXCL12 expression. Ueda Y; Yang K; Foster SJ; Kondo M; Kelsoe G J Exp Med; 2004 Jan; 199(1):47-58. PubMed ID: 14707114 [TBL] [Abstract][Full Text] [Related]
13. A genetic lesion that arrests plasma cell homing to the bone marrow. Erickson LD; Lin LL; Duan B; Morel L; Noelle RJ Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12905-10. PubMed ID: 14555759 [TBL] [Abstract][Full Text] [Related]
14. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Odendahl M; Mei H; Hoyer BF; Jacobi AM; Hansen A; Muehlinghaus G; Berek C; Hiepe F; Manz R; Radbruch A; Dörner T Blood; 2005 Feb; 105(4):1614-21. PubMed ID: 15507523 [TBL] [Abstract][Full Text] [Related]
15. Finding a home for plasma cells--a niche to survive. Tellier J; Kallies A Eur J Immunol; 2014 Aug; 44(8):2243-6. PubMed ID: 24989963 [TBL] [Abstract][Full Text] [Related]
16. The chemokine SDF-1, stromal cell-derived factor 1, attracts early stage B cell precursors via the chemokine receptor CXCR4. D'Apuzzo M; Rolink A; Loetscher M; Hoxie JA; Clark-Lewis I; Melchers F; Baggiolini M; Moser B Eur J Immunol; 1997 Jul; 27(7):1788-93. PubMed ID: 9247593 [TBL] [Abstract][Full Text] [Related]
17. The effects of microenvironment and internal programming on plasma cell survival. Minges Wols HA; Ippolito JA; Yu Z; Palmer JL; White FA; Le PT; Witte PL Int Immunol; 2007 Jul; 19(7):837-46. PubMed ID: 17606982 [TBL] [Abstract][Full Text] [Related]
18. Complement C3a enhances CXCL12 (SDF-1)-mediated chemotaxis of bone marrow hematopoietic cells independently of C3a receptor. Honczarenko M; Ratajczak MZ; Nicholson-Weller A; Silberstein LE J Immunol; 2005 Sep; 175(6):3698-706. PubMed ID: 16148115 [TBL] [Abstract][Full Text] [Related]
19. The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. Minges Wols HA; Underhill GH; Kansas GS; Witte PL J Immunol; 2002 Oct; 169(8):4213-21. PubMed ID: 12370351 [TBL] [Abstract][Full Text] [Related]
20. Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells. Pellegrino A; Ria R; Di Pietro G; Cirulli T; Surico G; Pennisi A; Morabito F; Ribatti D; Vacca A Br J Haematol; 2005 Apr; 129(2):248-56. PubMed ID: 15813853 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]